Clinical Trials in Philadelphia

Showing 1-20 of 15,860 trials

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

NCT02286089

The main objective of the study is evaluation of the safety and tolerability of OpRegen - Human embryonic stem cell-derived retinal pigment epithelial (RPE) cells. The study will also include initial exploration of the ability of transplanted OpRegen cells to engraft, survive, and moderate disease progression.

Age-Related Macular Degeneration

Hoffmann-La Roche24 participantsStarted Apr 2015

San Francisco, California, United States • Cincinnati, Ohio, United States • Philadelphia, Pennsylvania, United States +4 more locations

Active Not RecruitingPhase 2< 1 mile

A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

NCT06736990

The goal of this clinical trial is to learn if the investigational drug CAL101 can help prevent further decline in lung function in adults with Idiopathic Pulmonary Fibrosis. Researchers will compare CAL101 with placebo to compare change from baseline in forced vital capacity (FVC). Participants will be randomly assigned to a study group that will receive an IV infusion of either the study medication or placebo about once a month for 6 months.

Idiopathic Pulmonary Fibrosis

Calluna Pharma AS150 participantsStarted Jun 2025

Los Angeles, California, United States • Denver, Colorado, United States • Miami, Florida, United States +51 more locations

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

Find Trials by Condition in Philadelphia

P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

A Study of Mirdametinib in People With Central Nervous System Tumors

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)

A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

Efficacy and Utility of Cxbladder Tests in Hematuria Patients

The PROMISE Pediatric Study 6 to 11 Years Old

A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

Exercise in Metastatic Breast Cancer: EMBody

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)